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Background: An important virulence factor of Klebsiella pneumoniae is the production of capsular polysaccharide
(CPS), a thick mucus layer that allows for evasion of the host's defense and creates a barrier against antibacterial
peptides. CPS production is driven mostly by the expression of genes located in a locus called cps, and the
resulting structure is used to distinguish between different serotypes (K types). In this study, we report the unique
genetic organization of the cps cluster from K. pneumoniae Kp13, a clinical isolate recovered during a large outbreak
of nosocomial infections that occurred in a Brazilian teaching hospital.
Results: A pyrosequencing-based approach showed that the cps region of Kp13 (cpsKp13) is 26.4 kbp in length and
contains genes common, although not universal, to other strains, such as the rmlBADC operon that codes for
L-rhamnose synthesis. cpsKp13 also presents some unique features, like the inversion of the wzy gene and a unique
repertoire of glycosyltransferases. In silico comparison of cpsKp13 RFLP pattern with 102 previously published cps
PCR-RFLP patterns showed that cpsKp13 is distinct from the C patterns of all other K serotypes. Furthermore, in vitro
serotyping showed only a weak reaction with capsular types K9 and K34. We confirm that K9 cps shares common
genes with cpsKp13 such as the rmlBADC operon, but lacks features like uge and Kp13-specific glycosyltransferases,
while K34 capsules contain three of the five sugars that potentially form the Kp13 CPS.
Conclusions: We report the first description of a cps cluster from a Brazilian clinical isolate of a KPC-producing K.
pneumoniae. The gathered data including K-serotyping support that Kp13’s K-antigen belongs to a novel capsular
serotype. The CPS of Kp13 probably includes L-rhamnose and D-galacturonate in its structure, among other
residues. Because genes involved in L-rhamnose biosynthesis are absent in humans, this pathway may represent
potential targets for the development of antimicrobial agents. Studying the capsular serotypes of clinical isolates is
of great importance for further development of vaccines and/or novel therapeutic agents. The distribution of
K-types among multidrug-resistant isolates is unknown, but our findings may encourage scientists to perform
K-antigen typing of KPC-producing strains worldwide.
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Klebsiella pneumoniae is a Gram-negative, rod-shaped
bacterium frequently associated with nosocomial and
community-acquired infections [1]. Over the past dec-
ade, healthcare practitioners have observed the rapid evo-
lution of antimicrobial resistance among K. pneumoniae
clinical isolates worldwide. The emergence and subse-
quent global spread of strains producing Klebsiella
pneumoniae carbapenemase (KPC) represents a signifi-
cant threat to public health [2]. The gene encoding this
β-lactam resistance factor is frequently carried along
with genes conferring resistance to multiple classes of
antimicrobial agents. As a result, the therapeutic options to
treat infections caused by KPC-producing K. pneumoniae
are generally scarce and in some instances limited to poly-
myxins [2].
The development of an effective response against K.
pneumoniae infections depends on the integrity of the
immune system. Indeed, many authors have provided
evidence that activation of the inflammatory response is
required to clear such infections [3–5]. Unfortunately, most
patients infected by multidrug-resistant K. pneumoniae
have serious underlying conditions and/or a compromised
immune status [1,6]. Capsule production is believed to be
one of the most important virulence factors for this species.
The polysaccharide matrix found on its cell surface may
prevent desiccation, confer adherence to host cells and pro-
tect it against both non-specific and specific host immunity
[7]. However, there are differences in the degree of viru-
lence conferred by different Klebsiella capsule types, pos-
sibly depending on the mannose and/or rhamnose content
of the CPS [1]. The K. pneumoniae capsule is generally
composed of acidic polysaccharides, including uronic acid
repeats and, in several instances, mannose, rhamnose,5’
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Figure 1 Overall organization of the cps cluster of K. pneumoniae Kp1
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conserved regions of the cps cluster as discussed in the text. A plot of the
below. The dashed horizontal line represents the mean GC content of thegalactose, pyruvate and fucose residues [8]. The genes
involved in the biosynthesis, transport and assembly of K.
pneumoniae and E. coli group 1 capsules are found at a
locus called cps, which is organized similarly in the two spe-
cies [9]. The biosynthetic process of both types of capsules
is also related between the two bacteria. Briefly, CPS syn-
thesis initially takes place on the cytoplasmic side of the
inner membrane with the assembly of individual sugar re-
peat residues which are linked by the sequential activities of
specific glycosyltransferases (GTs) [10]. These are then
flipped across the inner membrane by the action of the
Wzx protein and undergo polymerization by the Wzy pro-
tein [11]. Polymerization control and translocation of the
nascent polymer to the cell surface occurs with the coordi-
nated action of Wza, Wzb and Wzc proteins [12].
To date, a variety of cps gene clusters have been charac-
terized in Klebsiella spp., mostly from isolates recovered
in the USA, Asia and Europe [13–15]. To our knowledge,
there have been no studies on the cps organization of K.
pneumoniae isolates from Brazil, KPC-producing or other-
wise. Here, we report the unique cps organization of a
KPC-producing K. pneumoniae isolate showing multidrug
resistance. This bacterium was responsible for a large
nosocomial outbreak in a teaching hospital located in
Southern Brazil (Ana C. Gales, personal communication).Results and Discussion
General features of the cpsKp13 gene cluster
The cpsKp13 gene cluster is 26.4 kbp in length and con-
tains 20 open reading frames (ORFs) from galF to wzy
(Figure 1, Table 1). The average GC content of these
genes is 42%, which is lower than the average GC con-
tent of the entire Kp13 genome (57.5%, data not shown).3’
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Table 1 General features of the 20 coding sequences identified in the Kp13 cps gene cluster
ORF Size (bp) %GC Gene
name
Product EC number Best BLASTP hit
(accession number) (identity)
KP03136 900 59.02 galF UTP–glucose-1-phosphate uridylyltransferase 2.7.7.9 K. pneumoniae strain NK8 (BAI43699) (100%)
KP03135 627 58.41 orf2 Uncharacterized phosphatidic acid
phosphatase protein
3.1.3.4 K. pneumoniae strain MGH 78578 (ABR77932) (100%)
and strain VGH404 serotype K5 (BAI43755) (100%).
KP03809 1,431 55.99 wzi Capsule assembly 55.8 kDa protein K. pneumoniae strain VGH484 serotype K9
(BAI43775) (98%)
KP03808 1,131 45.15 wza Capsule polysaccharide export protein K. pneumoniae strain VGH484 serotype K9
(BAI43776) (97%)
KP03807 438 39.69 wzb Protein-tyrosine-phosphatase 3.1.3.48 K. pneumoniae strain MGH 78578 (ABR77929) (78%)
KP03806 2,154 35.61 wzc Uncharacterized tyrosine-protein kinase 2.7.10.- K. pneumoniae strain MGH 78578 (ABR77928) (79%)
KP31533 1,446 35.2 wbaP Undecaprenolphosphate Gal-1-P transferase 2.-.-.- K. pneumoniae strain MGH 78578 (ABR77927) (79%)
KP03804 906 37.51 orf8 Uncharacterized glycosyltransferase family 2 2.4.1- K. pneumoniae strain A1517 (BAF75773) (67%)
KP03803 894 30.99 orf9 Uncharacterized glycosyltransferase family 2 2.4.1- Dickeya dadantii (ADM97617) (63%)
KP03802 759 29.79 orf10 Uncharacterized glycosyltransferase 2.4.1.- D. dadantii (ADM97619) (57%)
KP31534 1,404 51.46 gnd 6-phosphogluconate dehydrogenase,
decarboxylating
1.1.1.44 K. pneumoniae strain VGH484 serotype K9
(BAI43786) (99%)
KP31530 1,062 59.25 rmlB dTDP-D-glucose 4,6-dehydratase 4.2.1.46 K. pneumoniae strain VGH484 serotype K9
(BAI43787) (98%)
KP03797 867 58.74 rmlA Glucose-1-phosphate thymidylyltransferase 2.7.7.24 Escherichia coli HS (EFK17576) (98%)
KP03796 888 61.5 rmlD dTDP-4-dehydrorhamnose reductase 1.1.1.133 K. pneumoniae strain MGH 78578 (ABR77913) (98%)
KP03795 552 54.41 rmlC dTDP-4-dehydrorhamnose 3,5-epimerase 5.1.3.13 K. pneumoniae strain VGH484 serotype K9
(BAI43790) (99%)
KP03794 1,164 50.82 ugd UDP-glucose 6-dehydrogenase 1.1.1.22 K. pneumoniae strain NK8 (BAI43716) (100%) and
strain VGH404 serotype K5 (BAI43755) (100%)
KP03793 999 41.92 uge-1 Uridine diphosphate galacturonate
4-epimerase
5.1.3.6 K. pneumoniae subsp. rhinoscleromatis ATCC
13884 (EEW43608) (97%)
KP31531 1,233 31.57 wzx K-antigen flippase Wzx E. coli TA27 (ZP_07523140) (64%)
KP03791 990 31.32 orf19 Uncharacterized glycosyltransferase family 2 2.4.1.- Cronobacter sakazakii (ABX51890) (33%)
KP03789 1,044 29.61 wzy K antigen polymerase Wzy Thermoanaerobacter wiegelii (ACF14522) (35%)
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other K. pneumoniae cps clusters [15].
The cpsKp13 has a genomic organization similar to
other K. pneumoniae cps clusters, and it can be divided
into three regions as shown in Figure 1. The 5’ end or
region 1 (from galF to wbaP) contains conserved genes
responsible for polymer assembly and translocation [12].
The central region or region 2 contains genes encoding
serotype-specific GTs and gnd. The 3’ end or region 3
is more variable among different capsular types, with
some containing the manCB operon that encodes
GDP-D-mannose, like serotypes K1 and K5 [15]. Simi-
larly to serotypes K9 and K52, the 3’ end of the cpsKp13
gene cluster contains the rmlBADC operon for the syn-
thesis of dTDP-L-rhamnose instead of the manCB op-
eron [15]. The genes wzx and wzy are also found in the
3’ region of the Kp13 cps cluster. This region is suc-
ceeded by defective IS elements and a prophage frag-
ment (Figure 1). The discussed conservation of region 1
and variability of region 2 can be readily observable ona comparison of the cps loci of different K-types depos-
ited in NCBI (Figure 2).
The cpsKp13 monosaccharide biosynthesis pathways: UDP-
D-glucuronate, UDP-D-galacturonate and L-rhamnose
As in other bacteria that produce group-1 capsules, galF
delimits the 5’ region of cpsKp13. This gene shows 100%
identity to the galF sequence present in K. pneumoniae
NK8 [GenBank:BAI43699], which codes for a UTP-glucose-
1-phosphate uridylyltransferase (EC 2.7.7.9, Figure 3).
This enzyme belongs to the nucleotidyltransferase family
and catalyzes the reaction UTP+α-D-glucose 1-phosphate
↔ diphosphate +UDP-D-glucose. This enzyme is import-
ant because UDP-D-glucose serves as a precursor for the
biosynthesis of bacterial lipopolysaccharides and capsular
polysaccharides. It is also possible that the galF product
interacts with the product of galU, thus elevating UDP-D-
glucose concentration in the cell and providing more ma-
terial for the synthesis of capsular polysaccharides [11]. In
fact, a galU homolog found in Kp13 outside the cps region
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Figure 2 (See legend on next page.)
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Figure 2 Comparison of sequenced K. pneumoniae cps loci. For each cps cluster, a two-way comparison with the clusters immediately above
and/or below is presented. The K-type of each compared cluster is shown in red, followed by the strain/isolate identification and its NCBI
accession number in parentheses. The blue segments connecting each cluster represent variably conserved (60–100% identity) regions among
them (from a BLASTN comparison with e-value≤ 10-4). Predicted glycosyltransferases are colored in orange, wzy and gnd homologs in yellow and
purple, respectively. N.T., new K-type; N.D., K-type not determined.
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Shigella flexneri [Swiss-Prot:P0AEP6]. Immediately
downstream of the rmlBADC operon, the gene ugd is
found (Figure 1). It encodes a UDP-glucose 6-dehydro-
genase (EC 1.1.1.22). As depicted in Figure 3, this en-
zyme converts UDP-D-glucose to UDP-D-glucuronate,
a common constituent of bacterial capsules [7]. As with
other sequences located in the 3’ region of the cpsKp13
gene cluster, this coding sequence exhibits remarkable
amino acid conservation. It is 100% identical to Ugd from
K. pneumoniae strains NK8 [GenBank:BAI43716] and
VGH404 serotype K5 [GenBank:BAI43755] (Table 1),
both studied by Shu et al. [15]. Uge catalyzes the con-
version of UDP-D-glucuronate to UDP-D-galacturonate
(Figure 3), which is also present in both bacterial capsules
and LPS. In fact, Kp13 has two copies of this gene, uge-1
(KP03793) and uge-2 (KP03786). A NAD-dependent epi-
merase domain (Pfam accession no. PF01370) is predicted
to occupy amino acids 4 to 230 in both Uge sequences.
Two copies of uge are also found in the genome of K.
pneumoniae subsp. rhinoscleromatis (which produces a
K3 capsule), one in the cps cluster and an inverted adja-
cent copy in the cluster for LPS synthesis [16]. As the K3
CPS contains D-galacturonate in its composition, uge wasD-Glucose 1-Phosphate
2.7.7.9 GalF/GalU
UDP-D-glucose
1.1.1.22
UDP-D-glucuronate
5.1.3.6
UDP-D-galacturonate
Ugd
Uge
5.1.3.2GalE
UDP-D-
galactose
Figure 3 Amino- and polyketide sugar production in K. pneumoniae K
dTDP-L-rhamnose are shown, as these residues could be present in the cap
cpsKp13 cluster are underlined.considered the last gene of its cps cluster [16] instead of
ugd as usually regarded [15,17]. In Kp13 uge-1 should also
be considered within the cps since the genes necessary to
the flippase and polymerase activities, wzx and wzy re-
spectively, are located downstream (Figure 1); therefore,
D-galacturonate could also form the Kp13 CPS compos-
ition. The effects of a uge null mutation on colonization
and virulence were studied in K. pneumoniae 52145,
which is a highly virulent strain able to colonize different
surfaces [18]. A uge deletion reduced colonization and
rendered the strain completely avirulent in an experimen-
tal model of pneumonia [18]. This suggests that the uge-1
and/or uge-2 mutation in Kp13 could have important,
measurable effects on colonization and virulence.
In the cpsKp13 cluster, genes encoding enzymes that
participate on the synthesis of dTDP-L-rhamnose from
glucose 1-phosphate are found immediately downstream
of the gnd gene (Figure 1). The rmlBADC genes were
found in three capsular serotypes studied by Shu et al.
[15]: K9, K14 and K52. In serotypes K9 and K52, these
genes are also found downstream of gnd. The lengths of
the products encoded by rmlA, rmlB, rmlC and rmlD
are shown in Table 1, along with the best BLAST hits
for these genes. The gene rmlA codes for a glucose-2.7.7.24
RmlA
dTDP-D-glucose
4.2.1.46
5.1.3.13
RmlB
4,6-dideoxy-4-oxo-
dTDP-D-glucose
RmlC
dTDP-4-oxo-L-rhamnose
1.1.1.133RmlD
dTDP-L-rhamnose
p13. Pathways leading to UDP-D-galacturonate, UDP-D-galactose and
sular structure of Kp13. Enzymes coded by genes present in the
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catalyzes the first reaction of L-rhamnose synthesis:
dTTP+α-D-glucose 1-phosphate! diphosphate + dTDP-
D-glucose (Figure 3). The second reaction is performed by
dTDP-D-glucose 4,6-dehydratase (EC 4.2.1.46, Figure 3),
the product of rmlB, which catalyzes the dehydration of
dTDP-D-glucose to dTDP-4-keto 6-deoxy-D-glucose. Epi-
merization at the C3’ and C5’ positions of this molecule is
performed by dTDP-4-dehydrorhamnose 3,5-epimerase
(rmlC, EC 5.1.3.13, Figure 3), producing dTDP-4-oxo-L-
rhamnose. Finally, dTDP-4-dehydrorhamnose reductase
(EC 1.1.1.133, Figure 3), encoded by rmlD, catalyzes the
reduction of dTDP-4-oxo-L-rhamnose to dTDP-L-rham-
nose, which can be subsequently linked to the capsular
polymer by a specific rhamnosyltransferase. All three con-
served regions (the Y-X3-K loop, the Wierenga motif G-X2-
G-X2-G and the STDYVF sequence) discussed by Giraud
and Naismith [19] are present in Kp13’s RmlD.
Whereas the chemical composition of the Kp13 capsule
remains to be determined, the pyrosequencing-based gen-
omic analysis of cpsKp13 allowed the identification of sugar
metabolic pathways. Genes encoding enzymes for the
biosynthesis of sugar nucleotide precursors in the Kp13
capsule, such as UDP-D-glucose, UDP-D-glucuronate,
UDP-D-galacturonate and dTDP-L-rhamnose, are found
in the cps cluster. Thus, the capsule of Kp13 may contain
any of these sugar nucleotide precursors. In particular, the
presence of two genes in the cps cluster encoding possible
rhamnosyltransferases suggests that L-rhamnose makes
up part of the Kp13 capsule (see discussion below). On
the other hand, galE (KP02995) was identified outside the
cps region, and it encodes a UDP-glucose 4-epimerase
with roles in the amino sugar and nucleotide sugar path-
ways producing UDP-D-galactose from UDP-D-glucose
(Figure 3). The presence of this gene suggests that the
capsule composition of Kp13 could also include UDP-D-
galactose derivatives. Neither the manA, manB and manC
genes of the cps cluster nor other genes of the mannose
and fucose biosynthesis pathways were identified in the
Kp13 genome. This suggests that the CPS of Kp13 does not
contain GDP-D-mannose or GDP-L-fucose derivatives.
Proteins involved in translocation, surface assembly and
polymerization: Wzi, Wza, Wzb, Wzc, Wzx and Wzy
The deduced amino acid sequences of the wzi and wza
genes found in cpsKp13 show 98% and 97% identity, re-
spectively, with homologs from K. pneumoniae VGH484
(Table 1), and both proteins were predicted to localize in
the outer membrane (PSORTb scores: Wzi, 9.52; Wza,
9.92). Moreover, a signal peptide was predicted for the
wzi gene product. Analysis of the secondary structure of
the Kp13 Wzi protein using PSIPRED showed that it is
rich in β-sheet regions (data not shown), an observation
that has been experimentally confirmed for a Wzihomolog in E. coli [GenBank:AAD21561.1] [20] which
shares 98% identity with that of Kp13. Also, Rahn et al.
[20] established the importance of the Wzi outer mem-
brane protein for capsule synthesis by showing that wzi
mutants have lower amounts of cell-associated capsular
polysaccharide.
The wza product of Kp13 has 92% identity with Wza
from E. coli [GenBank:AAD21562.1], which has been
shown to be an integral lipoprotein with exposed regions
on the cell surface. The E. coli protein forms a ring-like
structure responsible for polymer translocation through
the outer membrane [12]. Wzc and Wzb are a tyrosine
autokinase and its cognate acid phosphatase, respect-
ively, and they are ubiquitously found in group 1 capsule
clusters [12,21]. The Kp13 Wzc protein was predicted to
have two transmembrane regions, like its counterpart in
the K. pneumoniae strain Chedid, with which it shares
72% amino acid identity [Swiss-Prot:Q48452]. The inner
membrane is the probable location of Kp13’ Wzc
(PSORTb score 9.99), in agreement with its role in cap-
sule synthesis. Wzc is involved in the translocation of cap-
sular polysaccharide from the periplasm to the cellular
surface through formation of a complex with Wza [22].
Wzc undergoes autophosphorylation of its tyrosine-rich
C-terminal residues (of the last 17 residues in Kp13 Wzc,
eight are Tyr) potentially modulating the opening and
closing of the translocation channel [12]. The Wzb protein
(EC 3.1.3.48) of Kp13 is probably located in the cytoplasm
(PSORTb score: 9.26). Wzb catalyzes the removal of a
phosphate group from phosphorylated Wzc and is neces-
sary for continued polymerization of the repeat units [12].
Sequence conservation of the Wzy and Wzx proteins is
usually low [23]. The localization of wzx and wzy in Kp13
is different from that observed in various K-serotypes by
Shu et al. [15], in which the genes usually mapped up-
stream of gnd. In Kp13, both genes are located down-
stream of gnd, in region 3 of the cps cluster, and wzy is
transcribed in the opposite direction relative to other cps
genes. Wzx is an inner membrane protein that transfers
the polysaccharide units, assembled in the cytoplasm, into
the periplasm, thus acting as a flippase [12]. The Wzx pro-
tein from cpsKp13 has 10 predicted transmembrane seg-
ments and is 411 aa long, which is in agreement with a
previous study of this protein in E. coli that predicted 10–
12 transmembrane segments [23]. BLASTP against the
NCBI database shows that the best hit (64% identity) is a
putative Wzx protein from E. coli TA271 (NCBI accession
no. ZP_07523140, Table 1). A polysaccharide biosynthesis
domain (Pfam accession no. PF01943), common to Wzx
proteins, was found spanning amino acids 8 to 275 of
Kp13 Wzx.
Wzy from Kp13 is 348 aa long and also had 10 pre-
dicted transmembrane segments, similar to the Wzy
proteins of other Enterobacteriaceae that have 10–11
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to be a polysaccharide polymerase, although experimen-
tal evidence for this activity has not yet been reported
due to the technical difficulty of working with Wzy
in vitro [12]. NCBI BLASTP searches show that the best hit
(35% identity) for Wzy is a conserved protein from Ther-
moanaerobacter wiegelii [GenBank:ACF14522.1] (Table 1).
It is remarkable that the wzy gene from isolate Kp13 is
transcribed in the opposite direction compared to other
genes of the cps cluster, a characteristic that to our know-
ledge has not been reported for previously studied cps clus-
ters, as can be observed in Figure 2, where the position of
wzy within different K. pneumoniae cps loci is highlighted.
Downstream wzy, we have identified an 862-bp region
showing 70% identity to an IS element of the IS3 family
[GenBank:CP002438.1]. No terminal inverted repeats or
target site duplications were found in this element. Al-
though three ORFs identified within this putative IS
showed significant identity to distinct transposases, these
structures do not seem to encode functional enzymes.
The occurrence of mutations leading to premature stop
codons and/or frameshifts might have rendered this
transposase non-functional. Alternatively, this chimeric
structure could have resulted from homologous recom-
bination events with other transposase-encoding genes.
Upstream wzy, there is a 1539-bp ORF whose deduced
amino acid sequence shows 31% identity to a defective
tail fiber protein of a Mu-like prophage identified in
Dickeya dadantii [GenBank:ADM97620]. Notably, other
prophage genes were absent. The location of wzy be-
tween two defective mobile genetic elements suggests
that this gene may have been incorporated into Kp13’s
cps via an ancient horizontal gene transfer event. Subse-
quently, these mobile genetic elements may have been
truncated in order to assure that wzy would be perman-
ently present in the cpsKp13 region, which is desirable be-
cause capsule assembly is a Wzy-dependent process.
The conserved gene gnd, found in the central region of
cpsKp13, encodes a 468 aa protein (6-phosphogluconate
dehydrogenase, EC 1.1.1.44, Figure 3) that catalyzes the
conversion of 6-phospho-D-gluconate to D-ribulose 5-
phosphate during the third step of the pentose phosphate
pathway. This gene was found in all of the cps gene clusters
studied by Shu et al. [15] and shows a high degree of conser-
vation among them, which would be expected from an evo-
lutionary standpoint due to the central role of this metabolic
pathway. At the protein sequence level, the best hit (99%
identity) for Kp13’s gnd product is an ortholog from strain
VGH484, serotype K9 [GenBank:BAI43786.1] (Table 1).
Kp13’s cps gene cluster has five GTs: WbaP, Orf8, Orf9,
Orf10 and Orf19
The products of wbaP, orf8, orf9, orf10 and orf19 are
GTs, enzymes specialized on the polymerization of sugarmolecules into existing molecules, which can be carbo-
hydrates, lipids or proteins. Because of the variety of
modifications catalyzed by GTs it is difficult, based on
sequence analysis alone, to define the exact outcome of
each reaction [25], even though they may play an im-
portant part on the diversity of capsular structures
encountered in K. pneumoniae. The number of GTs in
K. pneumoniae’s cps cluster is variable, ranging from
three (serotypes K1 and K2) to six as reported by Shu
et al. [15]. Kp13 has a total of five GTs, four of these
located contiguously (wbaP, orf8, orf9 and orf10) and
one of them found on the 3’ end of the cluster (orf19).
All the GTs found on Kp13’s cps gene cluster have been
predicted to belong to the family 2 GTs, comprising
enzymes that use an inverting catalytic mechanism
which modifies the anomeric configuration of the trans-
ferred sugar [26]. wbaP (formerly rfbP) is the first GT
on Kp13’s cps gene cluster and encodes a 482 aa long UDP-
Gal::undecaprenolphosphate Gal-1-P transferase, which cat-
alyzes the initial transfer of galactose-1-phosphate to an
undecaprenol phosphate acceptor, thus initiating the cap-
sule polymer synthesis. This protein was predicted to be
located in the cytoplasmic membrane (PSORTb score: 10.0)
and may contain five transmembrane-spanning regions. A
conserved WbaP phosphotransferase domain (IPR017472,
e-value 7.5e-194) is also found ranging from amino acids 21
to 482. NCBI BLASTP searches showed identity of up to
80% with WbaP from other K. pneumoniae and E. coli. The
protein presents two conserved DxD motifs, which are
widespread in GTs and are thought to be involved in metal/
nucleotide binding and catalysis [27,28]: DED, ranging from
amino acids 356–358 and DVD, 442–444 aa. The latter has
been found in all but one of 12 different capsular serotypes
studied by Shu et al. [15]. orf8 (KP03804) encodes a 302 aa
uncharacterized GT whose amino acid sequence shows
67% identity (Table 1) with putative rhamnosyltransferases
from K. pneumoniae strain A1517 showing a unique capsu-
lar serotype [GenBank:BAF75773.1] [14]. The GT
encoded by orf9 (KP03803) is predicted to be 298 aa
long, with a best hit on NCBI BLASTP with a putative
dTDP-rhamnosyltransferase from D. dadantii [GenBank:
ADM97617.1] (63% identity, Table 1). D. dadantii is a dis-
tantly related plant pathogen of the Enterobacteriaceae
family. Interestingly, there is little similarity between orf9
and other K. pneumoniae sequences. The highest identity
match (31%) is with a putative rhamnosyltransferase from
strain VGH484 [GenBank:BAI43783.1]. The presence of
the rmlBADC genes (previously discussed) together with
the possible rhamnosyltransferases provides appealing evi-
dence that L-rhamnose makes part of Kp13’s capsular
structure. orf10, the third gene encoding a putative GT
located in region 2 of the Kp13 cps cluster, is predicted to
code for a 253 aa long protein with a conserved domain
of unknown function spanning amino acids 36 to 193
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(57% identity, Table 1) is also with a sequence encoding
a putative GT from D. dadantii [GenBank:
ADM97619.1]. There was no similarity between the
orf10 (KP03802) product and other published Klebsiella
sequences.
Finally, the last GT from cpsKp13, termed orf19, is
located on the 3’ end of the cps cluster and encodes a
predicted 330 aa product. This protein has similarity
with several uncharacterized GTs family 2 from different
Enterobacteriaceae, including E. coli TA271 [GenBank:
EGI36158.1] (58% identity), D. dadantii [GenBank:
ADM97622.1] (38%) and Cronobacter sakazakii [GenBank:
ABX51890.1] (34%). Only a general domain of the GTs
family 2 was found in this protein, spanning amino acids 7
to 145 (Pfam accession no. PF00535).
In silico serotyping
Using molecular serotyping for the cps cluster, Brisse
et al. [29] showed that very distinct PCR-RFLP patterns
(C patterns) were obtained for most of the K serotypes,
indicating that differences in antigenic specificity among
serotypes are due to differences in cps gene content.
Thus, we have also applied in silico molecular serotyping
to determine the capsular serotype of isolate Kp13. For
this approach, the sequence between the primers pub-
lished by Brisse et al. [29] was used to search in silico
for restriction sites of the HincII endonuclease. This se-
quence spanned 12,031 bp from wzi to gnd, and the in
silico restriction analysis identified 12 restriction sites,
corresponding to 11 restriction fragments (Table 2). The
fragments, ranging in size from 368 to 1,777 bp, were
selected for analysis as suggested by Brisse et al. [29]
(Table 2). The cpsKp13 RFLP pattern was compared to
102 previously published C patterns [29]. None of theTable 2 In silico HincII restriction pattern obtained for the 12
gene cluster
Start End Cut site
548 553 550
1,561 1,566 1,563
1,638 1,643 1,640
2,458 2,463 2,460
2,550 2,555 2,552
7,129 7,134 7,131
7,260 7,265 7,262
7,266 7,271 7,268
7,634 7,639 7,636
9,411 9,416 9,413
10,798 10,803 10,800
10,863 10,868 10,865
* Fragments used for this analysis are underlined.reference patterns matched the one displayed by Kp13
(see Additional file 1). The similarity score for Kp13 was
greater than 10.4 (MST cutoff value score ≥ 0.75), thus
providing additional evidence that Kp13 K-type is a new
serotype.
In vitro K-serotyping
Kp13 showed a weak positive reaction with both K9 and
K34 antisera that could not be resolved by modifying anti-
serum dilution or quellung reaction. This result is not sur-
prising since cross-reactions with the type-specific
antisera is commonly observed among K. pneumoniae
clinical isolates due to the activity of common genetic ele-
ments among distinct cps clusters [30]. In fact, the
rmlBADC genes are also present in the cps cluster dis-
played by serotype K9 [15], and its CPS is composed of D-
glucuronate, D-galactose and L-rhamnose residues [31].
Given the gene content of cpsKp13 and the presence of
galE on the Kp13 genome, these residues could all be
synthesized by this isolate, hence cross-reactions were not
unexpected. From the comparison of cpsKp13 and
cpsVGH484 (K9, Figure 2) it is clear that they have common
genes, but the Kp13 cps also has distinguishing features
like its repertoire of GTs, the presence of uge-1 and a dif-
ferent cluster organization (e.g. the positions of wzy and
wzx). In the same line of evidence, the CPS of serotype
K34 is composed of L-rhamnose, D-glucose and D-
galacturonate residues [32], all of which also potentially
present in the Kp13 CPS as discussed earlier, and D-
galacturonate being produced by the epimerase activity
from the uge-1 product. No cps sequences from K34 iso-
lates were found on public databases. Nevertheless, our
results indicate that Kp13 possess a unique serotype since
it showed a distinct RFLP pattern compared to those 102
patterns, including representatives of serotypes K9 and,031 bp sequence spanning wzi to gnd in the Kp13 cps
Restriction fragment size between adjacent sites* (bp)
1,013
77
820
92
4,579
131
6
368
1,777
1,387
65
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that cps-PCR genotyping seems to be a more sensitive and
specific way for detecting novel serotypes [14], and our
pyrosequencing-based approach together with the careful
scrutinization of each CDS in the cluster and the in vitro
results supports the finding that Kp13 synthesizes a novel
CPS.
Regulation of cps gene expression in Kp13
The transcriptional regulation of cps genes is thought to
be under the control of three promoters, P1, P2 and P3,
which are located upstream of galF, wzi and rmlB, re-
spectively [13,15]. As previously shown for other strains
by Shu et al. [15], in the cpsKp13 cluster the transcripts
driven by P1 and P2 should consist of galF/orf2 and wzi
to gnd, respectively (Figure 4). Regulatory elements have
been identified within the promoters P1 and P2 of the
cpsKp13 cluster. Promoter P1 contains the regulatory
RcsAB box operator (5-TAAGATTATTCTCA-3’) that is
essential for the induction of Rcs-regulated promoters
by way of its interaction with the regulators RcsB and
RcsA [33]. Predicted rcsB and rcsA genes are present in
the Kp13 genome, encoded, respectively, by predicted
coding sequences KP00953 and KP04844.
The JUMPStart element was found within promoter
P2 (Figure 4). This element was identified upstream of a
number of bacterial cps clusters [15,34]. The 8-bp ops
element (5’-GGCGGTAG-3’) is located within JUMP-
Start and has been reported to function as a binding site
for the RfaH activator protein [35]. Indeed, rfaH is found
elsewhere in the Kp13 genome (KP31625), and its
deduced amino acid sequence displays 80% identity with
an ortholog from E. coli K12 [Swiss-Prot:P0AFW0]. A
possible stem-loop structure (Figure 4) related to the
Rho-independent transcription attenuator is located in
the intergenic region between wzc and wbaP of the
cpsKp13 cluster, as predicted by the ARNold web server
[36] with a calculated free energy of −8.49 kcal/mol.
Similar features have also been identified in other cps
clusters from K. pneumoniae [9,15]. Additionally, a sec-
ond putative stem-loop structure (Figure 4) was pre-
dicted downstream of orf10 (ΔG=−8.20 kcal/mol).
Further studies are necessary to confirm the implications5’
P1
galF orf2 wzi
P2
wzc wbaP
Figure 4 Model of regulation in the K. pneumoniae Kp13 cps cluster.
down triangles, and the JUMPStart element is shown as a hexagon. The re
stems are possible Rho-independent attenuators. P3 could either drive the
(P4, P5 or P6). The possible transcriptional units are depicted.of this finding; a stem-loop in this position has not been
previously described. The transcription of cpsKp13 region
3 may occur from different promoters. For instance, the
P3 promoter upstream rmlB may transcribe a polycistro-
nic mRNA from this gene up to orf19 or, alternatively,
each individual promoter predicted in this region may
drive the transcription of a limited number of genes
(Figure 4).
Notably, wzy is located between defective mobile ele-
ments and is transcribed in the opposite direction of
other genes in the cps cluster (Figure 1). Thus, it should
have its own promoter (possibly P7). A putative −10 box
was found, separated by 15 bp from its −35 counterpart,
but no obvious RBS could be identified. This observation
raises the question of how Kp13 coordinates expression
of wzy, since this protein is also essential for the forma-
tion of CPS.
Deviations from the −10 and −35 consensus sequences
significantly modify the strength of each promoter [37],
so the number of promoters could in fact be different
from that proposed here. Still, their roles in cps cluster
regulation deserve further experimental study, and our
sequence-based bioinformatic approach provides candi-
dates for follow-up.
Conclusions
In this study, we report a unique cps cluster organization
in Kp13, a multidrug-resistant, KPC-producing K. pneu-
moniae strain that caused a large outbreak in a Brazilian
teaching hospital. The Kp13 cps cluster contains all of
the genes necessary for capsule biosynthesis. Based on
the sugar metabolic pathways identified in cpsKp13 and in
other genomic regions, we have predicted that the cap-
sule composition of Kp13 may include D-glucose, D-
glucuronate, D-galacturonate, D-galactose and L-rhamnose
residues.
Methods
Ethics statement
This study was approved by the Ethics Committee of the
Universidade Estadual de Londrina (UEL) under refer-
ence number CAAE: 3356.0.000.268-09. Clinical assess-
ment and blood sampling were performed after diagnostic3’
gnd
P3 P4 P5 P6
uge-1Brml ugd
P7
wzywzx orf19
Only selected genes are shown. The promoters are depicted as upside-
ctangles under each cluster represent transcriptional units, and the
transcription of rmlB through orf19 or there could be other promoters
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Universitário-UEL, with written informed consent of the
patient.
Bacterial strain
Between February and May 2009, a teaching hospital located
in Southern Brazil experienced its first outbreak of nosoco-
mial infections due to KPC-producing K. pneumoniae. The
KPC-producing K. pneumoniae isolate Kp13 was recovered
from the blood culture of a patient admitted to the intensive
care unit with diabetes mellitus and cranial encephalic
trauma. Automated bacterial identification was conducted
with a MicroScan WalkAway apparatus (Dade Behring,
Sacramento, CA, USA). Kp13 was phenotypically detected
as a carbapenemase producer by the modified Hodge [38],
and the specific blaKPC-2 gene was identified by PCR and
amplicon sequencing using previously described primers
and cycling conditions [39].
Kp13 was identified as K. pneumoniae subsp. pneumoniae
by showing that its rpoB gene has 99% identity to rpoB of
K. pneumoniae subsp. pneumoniae strain MGH 78578
[GenBank:ABR79724.1].
DNA sequencing, assembly and sequence analysis
Genome sequencing of Kp13 was performed at the Uni-
dade Genômica Computacional - UGC/LNCC Facility
(http://www.labinfo.lncc.br/index.php/ugc) located in
Petrópolis, Rio de Janeiro, Brazil, using the Genome FLX
sequencer (454 Life Science/Roche). Both shotgun and
3 kb paired-end libraries were constructed, and sequen-
cing was carried out using FLX-Titanium chemistry. A
paired-end (PE) library analysis was applied to determine
the orientation and relative position of contigs produced
by de novo shotgun sequencing. The data consisted of a
total of 1,336,815 whole-genome shotgun reads and
558,997 paired-end reads.
Assembly of the sequence data into contigs and scaf-
folds was performed using the GS De Novo Assembler
software provided by 454 Life Sciences/Roche (v 2.5).
The high-quality reads were assembled into 151 contigs
and 15 scaffolds, comprising 5.9 Mb of sequence. For
the cpsKp13 region from galF to wzy, 99.9% of the bases
had Phred-like quality ≥ 60. The SABIA annotation pipe-
line [40] was used to predict protein-coding genes and
non-coding RNA genes. With the aim of detecting
complete cpsKp13 genes, functional annotation of the
ORFs was performed by searching the NCBI non-
redundant protein database using BLASTX, followed by
manual curation.
Protein subcellular localizations and signal peptides
were predicted using PSORTb 3.0 [41] with default para-
meters for Gram-negative bacteria. A score of 7.5 was
considered to be the cutoff for identification of protein
localization. Transmembrane regions were analyzed usingTMHMM [42]. Protein secondary structures were pre-
dicted using the PSIPRED web server [43], available at
http://bioinf.cs.ucl.ac.uk/psipred. Prediction of promoters
was performed using the in-house SABIA platform as well
as the BPROM program (http://linux1.softberry.com),
which searches for promoters under the control of the
sigma factor 70. Ribosome binding sites search was per-
formed using the RBS finder software that is included in
the SABIA platform. EasyFig [44] was used to generate
the structural comparison of cpsKp13 and other sequenced
cps loci.
In silico serotyping
An in silico serotyping approach was applied using the
Molecular Serotyping Tool (MST) [45]. MST is a pro-
gram for computer-assisted molecular identification of
restriction fragment length polymorphisms (RFLP) pat-
terns, in which the concepts of similarity and alignment
between RFLP patterns were adapted from Needleman
and Wunsch's dynamic programming algorithm. By ana-
logy, RFLP patterns represented by ordered fragment
sizes can be aligned, and their similarity can be calcu-
lated as the sum of penalties for edit operations (inser-
tions, deletions or substitutions) that transform one
pattern into another [45]. MST, available at www.cebio.
org/mst, was originally designed for the identification of
RFLP patterns from Escherichia coli and the Shigella O-
antigen gene clusters [46,47]. At present, identification
of K. pneumoniae serotypes can also be achieved be-
cause the RFLP patterns of the amplified capsular anti-
gen gene clusters of all known Klebsiella serotypes were
published by Brisse et al. [29].The RFLP of Kp13 was
determined and compared to those already described. All
scores were used to build a distance matrix in a PHYLIP
compatible format [48]. The distance matrix was used to
reconstruct a phylogeny by the UPGMA method with the
NEIGHBOR program, available in the PHYLIP package.
The tree generated by UPGMA was visualized with the
graphical viewer FIGTREE (http://tree.bio.ed.ac.uk/soft-
ware/figtree/). To improve the analysis of the UPGMA
tree, the two-time-scales were applied. The MST distance
cutoff that is able to distinguish between two serotypes is
1.5, and the scale-adjusted measure should be interpreted
as 0.75.
In vitro K-serotyping
Isolate Kp13 was sent to the International Escherichia
and Klebsiella Reference Center (WHO), Statens Serum
Institut, Copenhagen, Denmark, for serotyping. Briefly,
K-typing was done by counter-current immunoelectro-
phoresis (CCIE) against antiserum pools as previously
described [49]. Then, Kp13 was tested against with the
specific K-antisera of the reacting pool. The presence of
a visible capsule by wet-mount microscopy with Indian
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antisera since a cross-reaction had occurred.
Nucleotide sequence accession numbers
The cpsKp13 sequence and annotations are available from
Genbank (http://www.ncbi.nlm.nih.gov/Genbank) under
accession number [GenBank:JN377737]. The GenBank ac-
cession numbers for other sequences discussed in the
manuscript are [GenBank:JN377738] (galE), [GenBank:
JN377739] (galU), [GenBank:JN377740] (rfaH), [GenBank:
JN377741] (rcsB) and [GenBank:JN377742] (rcsA).
Additional file
Additional file 1: Cluster analysis of 103 RFLP patterns after MST
analysis. MST distances between serotypes are represented as alignment
scores, with 0.75 used as the scale-adjusted threshold for distinguishing
two serotypes. K. pneumoniae Kp13 is labeled as KP13, while the other
serotypes follow the C-pattern nomenclature from Brisse et al. [29].
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